Distinguishing Early-Stage Pancreatic Cancer Patients From Disease-Free Individuals Using Serum Profiling

REFERENCES

• American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society, 2009.
   Google Scholar
• Jones S, Zhang X, Parson DW, Lin JCH, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801–1806.
   PubMed Web of Science ®Google Scholar
• Pleasance ED, Stephens PJ, O'Meara, S., McBride DJ, Meynert A, Jones D, Lin M, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordonez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal A, Campbell PJ. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010;463:184–190.
   PubMed Web of Science ®Google Scholar
• Gattani AM, Mandeli J, Bruckner HW. Tumor markers in patients with pancreatic carcinoma. Cancer 1996;78:57–62.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prevent Res 2009;2:807–813.
   PubMed Web of Science ®Google Scholar
• Richter R, Schuz-Knappe, P., Schrader M, Standker L, Jurgens M, Tammen H, Forssman WG. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatog B Biomed Sci Appl 1999;726:25–35.
   PubMed Web of Science ®Google Scholar
• Hanas JS, Hocker JR, Cheung JY, Larabee JL, Lerner MR, Lightfoot SA, Morgan DL, Denson KD, Prejeant KC, Gusev Y, Smith BJ, Hanas RJ, Postier RG, Brackett DJ. Biomarker identification in human pancreatic cancer sera. Pancreas 2008;36:61–69.
   PubMed Web of Science ®Google Scholar
• Chambers G, Lawrie L, Cash P, Murray GL. Proteomics: a new approach to the study of disease. J Pathol 2000;192:280–288.
   PubMed Web of Science ®Google Scholar
• Verma M, Wright, GL Jr, Hanash SM, Gopal-Srivastava, R., Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Annal NY Acad Sci 2001;945:103–115.
   PubMed Web of Science ®Google Scholar
• Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage, H., Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271–284.
   PubMed Web of Science ®Google Scholar
• Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin JW, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005;51:102–112.
   PubMed Web of Science ®Google Scholar
• Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformat 2003;4:24.
   PubMed Web of Science ®Google Scholar
• Hortin GL. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin Chem 2005;51:3–5.
   PubMed Web of Science ®Google Scholar
• Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 2005;5:1–7.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;481:296–304.
   Google Scholar
• Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncol 2005;68:79–86.
   Google Scholar
• Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309–314.
   PubMed Web of Science ®Google Scholar
• Guan W, Zhou M, Hampton CY, Benigno BB, Walker LD, Gray A, McDonald JF, Fernández, FM. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinformatics 2009;10: 259–274.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind C. International Union Against Cancer; TNM: Classification of Malignant Tumors, 6th edition. New York, NY: Wiley-Liss, 2002.
   Google Scholar
• Altman DG, Bland M. Statistics notes: diagnostic tests 2: predictive values. Brit Med J 1994;309:102.
   PubMed Web of Science ®Google Scholar
• Altman DG, Bland M. Statistics notes: diagnostic tests 1: sensitivity and specificity. Brit Med J 1994;308:1552.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. User Evaluation of Precision Performance of Clinical Chemistry Devices. NCCLS Tentative Guideline EP5-T. Wayne, PA: June 1984.
   Google Scholar
• Postier RG, Lerner MR, Lightfoot SA, Vannarath R, Lane MM, Hanas JS, Brackett DJ. DNA ploidy and Markovian analysis of neoplastic progression in experimental pancreatic cancer. J Histochem Cytochem 2003;51:303–309.
   PubMed Web of Science ®Google Scholar